JAPMAJournal of the American Podiatric Medical Association
References in periodicals archive ?
This paper (JAPMA 102(2): 169-171, 2012) is the third in a series of peer reviewed articles published in JAPMA about Nomir's Noveon Laser.
This latest paper is a companion to the 180 day data presented in the second JAPMA paper and provides additional details after the longer follow-up time frame of 270 days.
This third publication in JAPMA adds further evidence to the growing body of positive Noveon clinical and laboratory data.